Neuronetics, Inc., (NASDAQ: STIM) (the 'Company” or 'Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the ...

The link between the ByHeart infant formula, voluntarily recalled by the company, and the outbreak is currently being ...

But CMS, under the leadership of Dr. Mehmet Oz, removed questions about a patient’s race and ethnicity in June. Advocates ...

You may have heard about using magnesium for anxiety, but does it actually work? Learn about the benefits and drawbacks of using magnesium for anxiety.

Fred Hutch's Value in Cancer Care conference, held November 6, focused on patient and provider burnout; the growing data ...

Discover key insights from Vivos Therapeutics’ Q3 2025 earnings: strategic growth, 76% revenue surge, and future outlook in sleep disorder treatment.

"It allows young adults with autism to maintain necessary supports during a critical transition period in their life." ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to DPTX3186, a first in class oral condensate ...

Q3 2025 Earnings Call November 19, 2025 5:00 PM ESTCompany ParticipantsBradford Amman - CFO, Treasurer & SecretaryR.

The bill also controversially establishes limits on taking people into custody who are on courthouse grounds for civil offenses, prohibits law enforcement personnel from carrying out their duties ...

The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...